Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-01-11T02:09:24.913Z Has data issue: false hasContentIssue false
  • English
  • Français

Can the chronic fatigue syndrome be defined by distinct clinical features?

Published online by Cambridge University Press:  09 July 2009

I. Hickie ,
A. Lloyd ,
D. Hadzi-Pavlovic ,
G. Parker ,
K. Bird  and
D. Wakefield
I. Hickie*
Affiliation:
School of Psychiatry, University of New South Wales; Mood Disorders Unit and Department of Immunopathology, Prince Henry Hospital, Sydney, NSW, Australia
A. Lloyd
Affiliation:
School of Psychiatry, University of New South Wales; Mood Disorders Unit and Department of Immunopathology, Prince Henry Hospital, Sydney, NSW, Australia
D. Hadzi-Pavlovic
Affiliation:
School of Psychiatry, University of New South Wales; Mood Disorders Unit and Department of Immunopathology, Prince Henry Hospital, Sydney, NSW, Australia
G. Parker
Affiliation:
School of Psychiatry, University of New South Wales; Mood Disorders Unit and Department of Immunopathology, Prince Henry Hospital, Sydney, NSW, Australia
K. Bird
Affiliation:
School of Psychiatry, University of New South Wales; Mood Disorders Unit and Department of Immunopathology, Prince Henry Hospital, Sydney, NSW, Australia
D. Wakefield
Affiliation:
School of Psychiatry, University of New South Wales; Mood Disorders Unit and Department of Immunopathology, Prince Henry Hospital, Sydney, NSW, Australia
*
1Address for correspondence: Dr Ian Hickie, The St George Hospital, Academic Department of Psychiatry, 7 Chapel Street, Kogarah, NSM 2217, Australia.
Get access Rights & Permissions [Opens in a new window]

Synopsis

To determine whether patients diagnosed as having chronic fatigue syndrome (CFS) constitute a clinically homogeneous class, multivariate statistical analyses were used to derive symptom patterns and potential patient subclasses in 565 patients. The notion that patients currently diagnosed as having CFS constitute a single homogeneous class was rejected. An alternative set of clinical subgroups was derived. The validity of these subgroups was assessed by sociodemographic, psychiatric, immunological and illness behaviour variables. A two-class statistical solution was considered most coherent, with patients from the smaller class (27% of the sample) having clinical characteristics suggestive of somatoform disorders. The larger class (73% of sample) presented a more limited combination of fatigue and neuropsychological symptoms, and only moderate disability but remained heterogeneous clinically. The two patient groups differed with regard to duration of illness, spontaneous recovery, severity of current psychological morbidity, utilization of medical services and CD8 T cell subset counts. The distribution of symptoms among patients was not unimodal, supporting the notion that differences between the proposed subclasses were not due simply to differences in symptom severity. This study demonstrated clinical heterogeneity among patients currently diagnosed as CFS, suggesting aetiological heterogeneity. In the absence of discriminative clinical features, current consensus criteria do not necessarily reduce the heterogeneity of patients recruited to CFS research studies.

Type
Original Articles
Information
Psychological Medicine , Volume 25 , Issue 5 , September 1995 , pp. 925 - 935
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abbey, S. & Garfinkel, P. (1991). Neurasthenia and chronic fatigue syndrome. The role of culture in the making of a diagnosis. American Journal of Psychiatry 148, 1638–1646.Google ScholarPubMed
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd ed – revised. APA: Washington.Google Scholar
Bakheit, A. M. O., Behan, P. O., Dinan, T. G., Gray, C. E. & O'Keane, V. (1992). Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with post-viral fatigue syndrome. British Medical Journal 304, 1010–1012.CrossRefGoogle Scholar
Bartholomew, D. J. (1987). Latent Variable Models and Factor Analysis. Charles Griffin: London.Google Scholar
Buchwald, D. & Komaroff, A. L. (1991). A review of laboratory findings for patients with chronic fatigue syndrome. Reviews of Infectious Diseases 13, S12–S18.CrossRefGoogle ScholarPubMed
Butler, S., Chalder, T., Ron, M. & Wessely, S. (1991). Cognitive behaviour therapy in the chronic fatigue syndrome. Journal of Neurology, Neurosurgery and Psychiatry 54, 153–158.CrossRefGoogle ScholarPubMed
Demitrack, M. A. & Greden, J. F. (1991). Chronic fatigue syndrome: the need for an integrative approach. Biological Psychiatry 30, 747–752.CrossRefGoogle ScholarPubMed
Demitrack, M. A., Dale, J. K. & Straus, S. E. (1991). Evidence for impaired activation of the hypothalamic–pituitary–adrenal axis in patients with chronic fatigue syndrome. Journal of Clinical Endocrinology and Metabolism 73, 1224–1234.CrossRefGoogle ScholarPubMed
Denicoff, K. D., Rubinow, D. R. & Papa, M. Z. (1987). The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Annals of Internal Medicine 107, 293–300.CrossRefGoogle ScholarPubMed
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G. & Komaroff, A. (1994). Chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 121, 953–959.CrossRefGoogle ScholarPubMed
Gold, D., Bowden, R., Sixby, J., Riggs, R., Katon, W. J., Ashley, R., Abrigentia, R. M. & Coney, L. (1990). Chronic fatigue: a prospective clinical and virological study. Journal of the American Medical Association 264, 48–53.CrossRefGoogle Scholar
Goldberg, D. P. (1979). Manual of the General Health Questionnaire. NFER Publishing Co.: Windsor.Google Scholar
Goldberg, D. & Huxley, P. (1992). Common Mental Disorders: A Bio-Social Model. Routledge: London.Google Scholar
Hickie, I. & Lloyd, A. (1995). Are cytokines associated with neuropsychiatric syndromes in humans? International Journal of Immunopharmacology (suppl.) (in the press).Google Scholar
Hickie, I., Lloyd, A., Wakefield, D. & Parker, G. (1990). The psychiatric status of patients with chronic fatigue syndrome. British Journal of Psychiatry 156, 534–540.CrossRefGoogle ScholarPubMed
Hickie, I., Lloyd, A. & Wakefield, D. (1991). Chronic fatigue syndrome and depression. Lancet 337, 922–923.CrossRefGoogle ScholarPubMed
Hickie, I., Lloyd, A. & Wakefield, D. (1992). Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome. Australian and New Zealand Journal of Psychiatry 26, 249–256.CrossRefGoogle ScholarPubMed
Hickie, I., Hickie, C., Lloyd, A., Silove, D. & Wakefield, D. (1993). Impaired in vivo immune responses in patients with melancholia. British Journal of Psychiatry 162, 651–657.CrossRefGoogle ScholarPubMed
Holmes, G. P. (1991). Problems in design and analysis: defining the chronic fatigue syndrome. Reviews of Infectious Diseases 13, S53–S55.CrossRefGoogle Scholar
Holmes, G., Kaplan, J., Gantz, N., Komaroff, A. L., Schonberger, L. B., Straus, S. E., Jones, J. F., Dubois, R. E., Cunningham-Rundles, C., Pahwa, S., Tosato, G., Zegans, L. S., Purtilo, D. T., Brown, N., Schooley, R. T. & Brus, I. (1988). Chronic fatigue syndrome: a working case definition. Annals of Internal Medicine 108, 387–389.CrossRefGoogle ScholarPubMed
Jones, J. F., Ray, C. G., Minnich, L. L., Hicks, M. J., Kilber, R. & Lucas, D. O. (1985). Evidence for active Epstein–Barr virus infection in patients with persistent unexplaind illness: elevated anti-early antibodies. Annals of Internal Medicine 102, 1–7.CrossRefGoogle Scholar
Katon, W. & Russo, J. (1992). Chronic fatigue syndrome criteria: a critique of the requirement for multiple physical complaints. Archives of Internal Medicine 152, 1604–1609.CrossRefGoogle ScholarPubMed
Katon, W. & Walker, E. A. (1993). The relationship of chronic fatigue to psychiatric illness in community, primary care and teritary care samples. In Chronic Fatigue Syndrome (ed. Bock, G. R. and Whelan, J.), pp. 193–211. John Wiley & Sons: Chichester.Google Scholar
Katon, W., Lin, E., VonKorff, M., Russo, J., Lipscomb, P. & Bush, T. (1991). Somatization: a spectrum of severity. American Journal of Psychiatry 148, 34–40.Google ScholarPubMed
Kendell, R. E. (1989). Clinical validity. Psychological Medicine 19, 45–55.CrossRefGoogle ScholarPubMed
Klimas, N. G., Salvato, F. R., Morgan, R. & Fletcher, M. A. (1990). Immunological abnormalities in chronic fatigue syndrome. Journal of Clinical Microbiology 28, 1403–1410.CrossRefGoogle ScholarPubMed
Komaroff, A. L. & Buchwald, D. (1991). Symptoms and signs of chronic fatigue syndrome. Reviews of Infectious Disease 13, S8–S11.CrossRefGoogle ScholarPubMed
Kraepelin, E. (1907). Clinical Psychiatry (ed. Watson, R. I.). Scholars Facsimiles and Reprints: New York (reprinted 1981).Google Scholar
Kruesi, M. J. P., Dale, J. & Straus, S. (1989). Psychiatric diagnosis in patients who have chronic fatigue. Journal of Clinical Psychiatry 50, 53–56.Google ScholarPubMed
Landay, A. L., Jessop, C., Lennette, E. T. & Levy, J. A. (1991). Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 338, 707–712.CrossRefGoogle ScholarPubMed
Lipowski, Z. J. (1988). Somatization: the concept and its clinical application. American Journal of Psychiatry 145, 1358–1367.Google ScholarPubMed
Lloyd, A., Wakefield, D., Boughton, C. & Dwyer, J. (1988). What is myalgic encephalomyelitis? Lancet i, 1286–1287.CrossRefGoogle Scholar
Lloyd, A. R., Wakefield, D., Dwyer, J. & Boughton, C. (1989). Immunological abnormalities in the chronic fatigue syndrome. Medical Journal of Australia 151, 122–124.CrossRefGoogle ScholarPubMed
Lloyd, A. R., Hickie, I., Boughton, C. R., Spencer, O. & Wakefield, D. (1990 a). Prevalence of chronic fatigue syndrome in an Australian population. Medical Journal of Australia 153, 522–528.CrossRefGoogle Scholar
Lloyd, A., Hickie, I., Wakefield, D., Dwyer, J. & Boughton, C. (1990 b). A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. American Journal of Medicine 89, 561–568.CrossRefGoogle ScholarPubMed
Lloyd, A., Hickie, I., Hickie, C. & Wakefield, D. (1991 a). Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clinical and Experimental Immunology 87, 76–79.CrossRefGoogle Scholar
Lloyd, A., Hickie, I., Brockman, A., Wakefield, D. & Dwyer, J. (1991 b). Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. Journal of Infectious Diseases 164, 1023–1024.CrossRefGoogle ScholarPubMed
Lloyd, A. R., Wakefield, D. & Hickie, I. (1993 a). Immunity and the pathophysiology of chronic fatigue syndrome. In Chronic Fatigue Syndrome (ed. Bock, G. R. and Whelan, J.), pp. 176–192. John Wiley & Sons: Chichester.Google ScholarPubMed
Lloyd, A., Hickie, I., Brockman, A., Hickie, C., Wilson, A., Dwyer, J. & Wakefield, D. (1993 b). Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. American Journal of Medicine 94, 197–203.CrossRefGoogle ScholarPubMed
McDonald, E. M., Mann, A. H. & Thomas, H. C. (1990). Interferons as mediators of psychiatric morbidity: an investigation in a trial of recombinant a-interferon in hepatitis-B carriers. Lancet 56, 1175–1177.Google Scholar
McKutcheon, A. L. (1987). Latent Class Analysis. Sage: Beverley Hills.CrossRefGoogle Scholar
McLachlan, G. J. & Basford, K. E. (1988). Mixture Models: Inference and Applications to Clustering. Marcel Dekker: New York.Google Scholar
Maes, M., Bosmans, E., Suy, E., Vandervorst, C., Dejonckheere, C. & Raus, J. (1991). Antiphospholipid, antinuclear, Epstein–Barr and cytomegalovirus antibodies and soluble interleukin-2 receptors in depressive patients. Journal of Affective Disorders 21, 133–140.CrossRefGoogle ScholarPubMed
Maes, M., Scharpe, S., Meltzer, H. Y.. & Cosyns, P. (1993). Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression. Biological Psychiatry 34, 690–701.CrossRefGoogle ScholarPubMed
Manu, P., Lane, T. J. & Matthews, D. A. (1988). The frequency of chronic fatigue syndrome in patients with symptoms of persistent fatigue. Annals of Internal Medicine 109, 554–556.CrossRefGoogle ScholarPubMed
Mayer-Gross, , Slater, E & Roth, M. (1969). Clinical Psychiatry (3rd edn), pp. 81–85. Baillière, Tindall and Cassell: London.Google Scholar
Moldofsky, H. (1933). Fibromyalgia, sleep disorder and chronic fatigue syndrome. In Chronic Fatigue Syndrome (ed. Bock, G. R. and Whelan, J.), pp. 262–279. John Wiley & Sons: Chichester.Google Scholar
Peterson, P. K., Shepard, J. & Macres, M. (1990). A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. American Journal of Medicine 89, 554–560.CrossRefGoogle ScholarPubMed
Pilowsky, I. (1991). Somatic symptoms and other related disorders. Current Opinions in Psychiatry 4, 220–224.CrossRefGoogle Scholar
Pilowsky, I. & Spence, N. D. (1983). Manual for the Illness Behaviour Questionnaire (IBQ – 2nd edn). University of Adelaide: Adelaide.Google Scholar
Schluederberg, A., Straus, S. E. & Peterson, P. (1992). Chronic fatigue syndrome research: definition and medical outcome assessment. Annals of Internal Medicine 117, 325–331.CrossRefGoogle ScholarPubMed
Sharpe, M. (1993). Non-pharmacological approaches to treatment. In Chronic Fatigue Syndrome (ed. Bock, G. R. and Whelan, J.), pp. 298–317. John Wiley & Sons: Chichester.Google Scholar
Sharpe, M. C., Archard, L. C., Banatvala, J. E., Borysiewicz, L. K., Clare, A. W. & David, A. (1991). A report – chronic fatigue syndrome: guidelines for research. Journal of the Royal Society of Medicine 84, 118–121.CrossRefGoogle ScholarPubMed
Shorter, E. (1993). Chronic fatigue in historical perspective. In Chronic Fatigue Syndrome (ed. Bock, G. R. and Whelan, J.), pp. 6–22. John Wiley & Sons: Chichester.Google Scholar
Straus, S. E. (1988). The chronic mononucleosis syndrome. Journal of Infectious Diseases 157, 405–412.CrossRefGoogle ScholarPubMed
Straus, S. E.. (1991). History of chronic fatigue syndrome. Reviews of Infectious Diseases 13, S2–S7.CrossRefGoogle ScholarPubMed
Straus, S. E., Tosato, G., Armstrong, G., Lawley, T., Preble, O. T., Henle, W., Davey, R., Pearson, G., Epstein, J., Brus, I. & Blaese, R. M. (1985). Persisting illness and fatigue in adults with evidence of Epstein–Barr virus infection. Annals of Internal Medicine 102, 7–16.CrossRefGoogle ScholarPubMed
Swartz, M. N. (1988). The chronic fatigue syndrome: one entity or many? New England Journal of Medicine 319, 1726–1728.CrossRefGoogle ScholarPubMed
Taerk, G. S., Toner, B. B. & Salit, I. E. (1987). Depression in patients with neuromyasthenia. International Journal of Psychiatry in Medicine 17, 49–56.CrossRefGoogle ScholarPubMed
Ware, N. C. & Kleinman, A. (1992). Culture and somatic experience: the social course of illness in neurasthenia and chronic fatigue syndrome. Psychosomatic Medicine 54, 546–560.CrossRefGoogle ScholarPubMed
Wessely, S. (1990). Old wine in new bottles: neurasthenia and ‘ME’. Psychological Medicine 20, 35–53.CrossRefGoogle Scholar
Wessely, S. (1993). The neuropsychiatry of chronic fatigue syndrome. In Chronic Fatigue Syndrome (ed. Bock, G. R. and Whelan, J.), pp. 212–237. John Wiley & Sons: Chichester.Google ScholarPubMed
Wessely, S. & Powell, R. (1989). Fatigue syndromes: a comparison of chronic ‘postviral’ fatigue with neuromuscular and affective disorders. Journal of Neurology, Neurosurgery and Psychiatry 52, 940–948.CrossRefGoogle ScholarPubMed
Wessely, S., David, A., Butler, S. & Chalder, T. (1988 a). The management of the chronic ‘post-viral’ syndrome. Journal of the Royal College of General Practitioners 39, 26–29.Google Scholar
White, P. (1989). Fatigue syndrome: neurasthenia revived. British Medical Journal 298, 1199–1200.CrossRefGoogle ScholarPubMed
Wilson, A., Hickie, I., Lloyd, A. & Wakefield, D. (1994 a). Science and speculation: the treatment of chronic fatigue syndrome. American Journal of Medicine 96, 544–550.CrossRefGoogle ScholarPubMed
Wilson, A., Hickie, I., Lloyd, A., Wakefield, D., Boughton, C. & Dwyer, J. (1994 b). Longitudinal study of outcome of chronic fatigue syndrome. British Medical Journal 308, 756–759.CrossRefGoogle ScholarPubMed